This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: University of Kansas. Active years: 1996-2013.
Location History:
- Kansas City, KS (US) (1996)
- Lenexa, KS (US) (2013)
Company Filing History:
Years Active: 1996-2013
Title: Innovations of James P. Calvet
Introduction
James P. Calvet is an accomplished inventor based in Lenexa, Kansas. He has made significant contributions to the field of medical research, particularly in the treatment of polycystic kidney disease. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Calvet's latest patents include innovative treatments involving lonidamine analogues. These derivatives are designed to inhibit and prevent polycystic kidney disease (PKD). The methods involve administering a therapeutically effective amount of these compounds to inhibit various biological pathways associated with PKD. Additionally, he has developed DNA sequences encoding a mouse phosphotriesterase-related protein, which may have further applications in pharmaceutical compositions.
Career Highlights
James P. Calvet is affiliated with the University of Kansas, where he conducts his research. His work is characterized by a commitment to advancing medical science and improving treatment options for patients suffering from kidney diseases.
Collaborations
Calvet has collaborated with notable colleagues, including Ramappa Chakrasali and Xiaoying Hou. These partnerships have fostered a collaborative environment that enhances the research output and innovation in their respective fields.
Conclusion
James P. Calvet's contributions to medical research through his patents and collaborations highlight his dedication to innovation in healthcare. His work continues to pave the way for new treatments and advancements in the understanding of polycystic kidney disease.